eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2023
vol. 25
 
Share:
Send email
Share:
Review paper

Herbal medicinal products in RESPIRATORY diseases – STANce of the Polish PHYTOtherapy Association – STANPHYTO RESPIRATORY I

Zbigniew Doniec
1, 2
,
Mirosława Krauze-Baranowska
3
,
Mieczysława Czerwionka-Szaflarska
4
,
Ernest Kuchar
5
,
Izabela Fecka
6
,
Adam Sybilski
7, 8
,
Jarosław Woroń
9
,
Agnieszka Mastalerz-Migas
10

  1. Pneumology Department, Institute of Tuberculosis and Lung Diseases, Field Branch, Rabka-Zdroj, Poland
  2. Medical Institute, Podhale State College of Applied Science, Nowy Targ, Poland
  3. Department of Pharmacognosy, Medical University of Gdansk, Poland
  4. A. Jurasz University Hospital, Department of Paediatrics, Allergology and Gastroenterology Clinic, Bydgoszcz, Poland
  5. Department of Paediatrics and Observation Unit, Medical University of Warsaw, Poland
  6. Department of Pharmacognosy and Herbal Medicines, Medical University of Wroclaw, Poland
  7. Department of Paediatric and Neonatal Diseases, National Medical Institute of the Ministry of Internal Affairs and Administration in Warsaw, Poland
  8. Department of Paediatrics II, Postgraduate Medical Education Center, Warsaw, Poland
  9. Department of Clinical Pharmacology, Jagiellonian University, Collegium Medicum of Cracow, Poland
  10. Chair and Department of Family Practice, Medical University of Wroclaw, Poland
Family Medicine & Primary Care Review 2023; 25(3): 331–338
DOI: https://doi.org/10.5114/fmpcr.2023.131270
Online publish date: 2023/09/30
Article file
- 15 FM&PCR 3 23 - R - Doniec - Herbal medicinal products I.pdf  [0.53 MB]
Get citation
 
PlumX metrics:
 
1. Denny FW Jr. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 1995; 152(4 Pt 2): S4–S12, doi: 10.1164/ajrccm/152.4_Pt_2.S4.
2. Berman S. Otitis Media in Developing Countries. Pediatrics 1995; 96(1 Pt 1): 126–131.
3. Undrunas A, Kuziemski K. Uporczywy kaszel – trudnoci diagnostyczno-terapeutyczne w codziennej praktyce lekarskiej. Forum Med Rodz 2017; 11(4): 149–155 (in Polish).
4. Krenke K, Doniec Z, Mastalerz-Migas M, et al. Zalecenia postpowania diagnostyczno-terapeutycznego w kaszlu u dzieci – aktualizacja. Lekarz POZ 2022; 3: 173–192 (in Polish).
5. Schönknecht K, Krauss H, Jambor J, et al. Treatment of cough in respiratory tract infections – the effect of combining the natural active compounds with thymol. Wiad Lek 2016; 69(6): 791–798.
6. Committee on Herbal Medicinal Products (HMPC). Available from URL: https://www.ema.europa.eu/en/committees/committee-herbal-medicinal-products-hmpc.
7. Farmakopea Polska wydanie XII. Available from URL: https://urpl.gov.pl/pl/urz%C4%85d/farmakopea/farmakopea-polska (in Polish).
8. European Union herbal monograph on Althaea officinalis L., radix; EMA/HMPC/436679/2015. Available from URL: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-althaea-officinalis-l-radix_en.pdf.
9. Assessment report on Plantago lanceolata L., folium; EMA/HMPC/437859/2010. Community herbal monograph on Plantago lanceolata L., folium; EMA/HMPC/437858/2010 Corr. Available from URL: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-plantago-lanceolata-l-folium_en.pdf.
10. Assessment report on Verbascum thapsus L., V. densiflorum Bertol. (V. thapsiforme Schrad) and V. phlomoides L., flos; EMA/HMPC/611531/2016, European Union herbal monograph on Verbascum thapsus L., V. densiflorum Bertol. (V. thapsiforme Schrad) and V. phlomoides L., flos; EMA/HMPC/611537/2016. Available from URL: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-verbascum-thapsus-l-v-densiflorum-bertol-v-thapsiforme-schrad_en.pdf.
11. Assessment report on Cetraria islandica (L.) Acharius s.l., thallus; EMA/HMPC/36866/2014 European Union herbal monograph on Cetraria islandica (L.) Acharius s.l., thallus; EMA/HMPC/678891/2013. Available from URL: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-cetraria-islandica-l-acharius-sl-thallus-first-version_en.pdf.
12. Assessment report on Hedera helix L., folium. 28 January 2015; EMA/HMPC/586887/2014 Committee on Herbal Medicinal Products (HMPC). Available from URL: https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-hedera-helix-l-folium_en.pdf.
13. Sieben A, Prenner L, Sorkalla T, et al. Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the winding behavior, dynamics and regulation of beta2-adrenergic receptors. Biochemistry 2009; 48: 3477–3482.
14. Schulte-Michels J, Runkel F, Gokorsch S, et al. Ivy leaves dry extract EA 575® decreases LPS-induced IL-6 release from murine macrophages. Pharmazie 2016; 71(3): 158–161.
15. Schulte-Michels J, Keksel C, Häberlein H, et al. Anti-inflammatory effects of ivy leaves dry extract: influence on transcriptional activity of NFB. Inflammopharmacology 2019; 27(2): 339–347, doi: 10.1007/s10787-018-0494-9.
16. Schaefer A, Ludwig F, Giannetti BM, et al. Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575® versus placebo in the treatment of acute bronchitis in adults. ERJ Open Res 2019; 5: 00019–2019.
17. Schaefer A, Kehr MS, Giannetti BM et al. A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575®) vs. placebo in the treatment of adults with acute cough. Pharmazie 2016; 71: 504–509.
18. Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med 2011; 2011: 382789.
19. Lang C, Staiger C, Wegener T. Ivy in everyday paediatric use: administration of EA 5751 to schoolchildren for the treatment of acute bronchitis. Z Phytother 2015; 36: 192–196.
20. Kruttschnitt E, Wegener T, Zahner C, et al. Assessment of the efficacy and safety of ivy leaf (Hedera helix) cough syr-up compared with acetylcysteine in adults and children with acute bronchitis. Evid Based Complement Alternat Med 2020; 2020: 1910656.
21. Schmidt M, Thomsen M, Schmidt U. Suitability of ivy extract for the treatment of paediatric cough. Phytother Res 2012; 26(12): 1942–1947, doi: 10.1002/ptr.4671.
22. Zeil S, Schwanebeck U, Vogelberg C. Tolerance and effect of an add-on treatment with a cough medicine contain-ing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine 2014; 21(10): 1216–1220, doi: 10.1016/j.phymed.2014.05.006.
23. Lang C, Röttger-Lüer P, Staiger C. A valuable option for the treatment of respiratory diseases: review on the clinical evidence of the ivy leaves dry extract EA 575®. Planta Med 2015; 81: 968–974.
24. European Union herbal monograph on Hedera helix L., folium, 21 November 2017 EMA/HMPC/325716/2017 Committee on Herbal Medicinal Products (HMPC). Available from URL: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-hedera-helix-l-folium-revision-2_en.pdf.
25. Hryniewicz W, Albecht P, Radzikowski A, eds. Rekomendacje postpowania w pozaszpitalnych zakaeniach ukadu oddechowego. Available from URL: https://antybiotyki.edu.pl/wp-content/uploads/Rekomendacje/Rekomendacje2016.pdf (in Polish).
26. Wienkotter N, Begrow F, Kinzinger U, et al. The effect of thyme extract on beta2-receptors and mucociliary clearance. Planta Med 2007; 73: 629–635.
27. Hammad M, Sallal AK, Darmani H. Inhibition of Streptococcus mutans adhesion to buccal epithelial cells by an aqueous extract of Thymus vulgaris. Int J Dent Hygiene 2007; 5: 232–233.
28. Tohidpour A, Sattari M, Omidbaigi R, et al. Antibacterial effect of essential oils from two medicinal plants against Methicillin-resistant Staphylococcus aureus (MRSA). Phytomed 2010; 17: 142–145.
29. Ocańa A, Reglero G. Effects of thyme extract oils (from Thymus vulgaris, Thymus zygis, and Thymus hyemalis) on cytokine production and gene expression of oxLDL-stimulated THP-1-macrophages. J Obes 2012; 2012: 10470.
30. Vimalanathan S, Hudson J. Anti-influenza virus activity of essential oils and vapors. Amer J Essential Oils Nat Prod 2014; 2: 47–53.
31. Gruenwald J, Graubaum HJ, Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo controlled clinical trial. Arzneimittelforschung 2005; 55: 669–676.
32. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and prim-rose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebocontrolled multicentre clinical trial. Arzneimittelforschung 2007; 57: 607–615.
33. Fal AM, Schönknecht K. Skuteczno i tolerancja syropu Bronchosol® w leczeniu ostrego zapalenia oskrzeli u dorosych. Porównanie z preparatami syntetycznymi zawierającymi ambroksol – badanie obserwacyjne. Wiad Lek 2015; LXVIII(2): 139–144 (in Polish).
34. Assessment report on Thymus vulgaris L., vulgaris zygis L., herba. 12 November 2013 EMA/HMPC/342334/2013 Committee on Herbal Medicinal Products (HMPC). Available from URL: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-thymus-vulgaris-l-vulgaris-zygis-l-herba_en.pdf.
35. Primulae radix (Primula root). Available from URL: https://escop.com/downloads/primulae-radix-primula-root-escop-2021/.
36. Community herbal monograph on Primula veris L. and/or Primula elatior (L.) Hill, radix, 19 September 2012 EMA/HMPC/104095/2012 Committee on Herbal Medicinal Products (HMPC). Available from URL: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-primula-veris-l/primula-elatior-l-hill-radix_en.pdf.
37. Nurzyska-Wierdak R. Aktywność biologiczna olejków eterycznych roślin z rodziny Pinaceae. Ann UMCS Sectio EEE Horticultura 2015; XXV(3): 19–31 (in Polish).
38. Rivas da Silva AC, Monteiro Lopes P, Barros de Azevedo MM, et al. Biological activities of -pinene and -pinene enanti-omers. Molecules 2012; 17: 6305–6316.
39. ESCOP Monographs. Foeniculi fructus. Available from URL: https://escop.com/wp-content/uploads/edd/2019/03/Foeniculi-fructus-ESCOP-2019.pdf.
40. Zalewska E, Nurzyńska-Wierdak R. Rośliny z rodziny Apiaceae źródłem surowca farmakopealnego. Ann UMCS Sectio EEE Horticultura 2016; XXVI(2): 47–60 (in Polish).
41. Chandra S, Rawat DS, Bhatt A. Phytochemistry and pharmacological activities of Saponaria officinalis L.: A review. Notulae Scientia Biologicae 2021; 13(1): 10809.
42. Jop B, Krajewska A, Wawrzyńczak K, et al. Phytotoxic Effect of Essential Oil from Hyssop (Hyssopus officinalis L.) against Spring Wheat and White Mustard. Biol Life Sci Forum 2021; 3(1): 13, doi: 10.3390/IECAG2021-09711.
43. Kizil S, Hasimi N, Tolan V, et al. Chemical Composition, Antimicrobial and Antioxidant Activities of Hyssop (Hyssopus officinalis L.) Essential Oil. Not Bot Hort Agrobot Cluj 2010; 38(3): 99–103.
44. Devi KP, Malar DS, Nabavi SF, et al. Kaempferol and inflammation: From chemistry to medicine. Pharmacol Res 2015; 99: 1–10, doi: 10.1016/j.phrs.2015.05.002.
45. Schulz V, Hansel R, Tyler VE. Rational phytotherapy. A physicians guide to herbal medicine. Berlin: Springer; 2001.
46. Sybilski AJ. Gorączka. In: Sybilski AJ, Woroń J, Życińska K, et al., eds. Gorączka, przyczyny, diagnostyka, leczenie. Warszawa: Medical Education; 2021: 53–65 (in Polish).
47. European Union herbal monograph on Salix [various species including S. purpurea L., S. daphnoides Vill., S. fragilis L.], cortex. Available from URL: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salix-various-species-including-s-purpurea-l-s-daphnoides-vill_en.pdf.
48. Edwards SE, Costa Rocha I, de, Williamson EM, et al. Fitofarmaceutyki – oparte na dowodach naukowych kompendium leczniczych produktów ziołowych. Warszawa: Wydawnictwo Lekarskie PZWL; 2022 (in Polish).
Copyright: © 2023 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.